{"id":"sebivo","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Breastfeeding (mother)","Disorder of muscle","Kidney disease","Lactic acidosis","Myositis","Peripheral nerve disease","Steatosis of liver"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":{"chemblId":"CHEMBL374731","moleculeType":"Small molecule","molecularWeight":"242.23"},"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{"target":"Capsid protein, Protein P"},"_scrapedAt":"2026-03-28T04:24:51.530Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Chronic type B viral hepatitis","diseaseId":"chronic-type-b-viral-hepatitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07459426","phase":"","title":"Entecavir Resistance-Associated Mutations in Chronic HBV Patients in Turkey (STREAM Study)","status":"NOT_YET_RECRUITING","sponsor":"Yaşar Bayındır, MD","startDate":"2026-03-15","conditions":"Hepatitis B, Chronic","enrollment":700},{"nctId":"NCT03736265","phase":"NA","title":"Carvedilol for Prevention of Esophageal Varices Progression","status":"UNKNOWN","sponsor":"Beijing Friendship Hospital","startDate":"2017-10-09","conditions":"Cirrhosis, Liver, Portal Hypertension","enrollment":240},{"nctId":"NCT01143779","phase":"PHASE1","title":"FLT-PET as an Imaging Biomarker With Temsirolimus, Topotecan, and Bortezomib","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2010-06","conditions":"Advanced Cancer","enrollment":3},{"nctId":"NCT00051090","phase":"NA","title":"Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV","status":"WITHDRAWN","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections, Hepatitis B","enrollment":""},{"nctId":"NCT05021406","phase":"NA","title":"Extension Study of Carvedilol RCT Study","status":"UNKNOWN","sponsor":"Beijing Friendship Hospital","startDate":"2021-01-08","conditions":"Liver Cirrhosis, Portal Hypertension","enrollment":240},{"nctId":"NCT03491553","phase":"PHASE2","title":"Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Participants With Chronic Hepatitis B","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2018-04-06","conditions":"Chronic Hepatitis B","enrollment":48},{"nctId":"NCT04724785","phase":"","title":"Real World Study About Anti-viral Regimen Adjustment on Achieving Complete Response in CHB Patients","status":"UNKNOWN","sponsor":"The Second Affiliated Hospital of Chongqing Medical University","startDate":"2020-12-01","conditions":"Sustained Virologic Response, Hepatitis B, Chronic","enrollment":10000},{"nctId":"NCT01410630","phase":"","title":"FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2017-09-07","conditions":"Lymphoma, Lymphoma, Non-Hodgkin, Large B Cell Diffuse Lymphoma","enrollment":66},{"nctId":"NCT03366571","phase":"","title":"Improvement of Hard Endpoint in Chronic Hepatitis B Patients Treated With Antiviral Therapy","status":"UNKNOWN","sponsor":"Beijing Friendship Hospital","startDate":"2016-01","conditions":"Chronic Hepatitis B","enrollment":600},{"nctId":"NCT04650828","phase":"","title":"TDF Combined With LDT for the Treatment of HBeAg-positive Hepatitis B Patients With Poor Response to TDF for 12 Months","status":"UNKNOWN","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2020-12-01","conditions":"Chronic Hepatitis B","enrollment":200},{"nctId":"NCT00907894","phase":"PHASE1","title":"Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis B","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2009-02","conditions":"Chronic Hepatitis B","enrollment":22},{"nctId":"NCT01935635","phase":"PHASE1, PHASE2","title":"A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHB","status":"COMPLETED","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2015-01","conditions":"Chronic Hepatitis B","enrollment":400},{"nctId":"NCT03116542","phase":"NA","title":"18F-FLT (PET/CT) in Prefibrotic/Early Primary Myelofibrosis and Essential Thrombocythemia","status":"UNKNOWN","sponsor":"Hamad Medical Corporation","startDate":"2017-05-07","conditions":"Essential Thrombocythemia, Primary Myelofibrosis, Fibrotic Stage, Primary Myelofibrosis, Prefibrotic Stage","enrollment":21},{"nctId":"NCT00142298","phase":"PHASE3","title":"Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2005-03","conditions":"Chronic Hepatitis B","enrollment":1869},{"nctId":"NCT02746367","phase":"","title":"Bipolar Proteomic Assay Validation Study","status":"COMPLETED","sponsor":"Myriad Genetic Laboratories, Inc.","startDate":"2016-03","conditions":"Major Depressive Disorder, Bipolar I and Bipolar II","enrollment":261},{"nctId":"NCT01117155","phase":"","title":"A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas","status":"WITHDRAWN","sponsor":"National Cancer Institute (NCI)","startDate":"2010-04-23","conditions":"Ependymoma, Brainstem Glioma, Astrocytoma","enrollment":""},{"nctId":"NCT01943799","phase":"PHASE2","title":"Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2013-09-13","conditions":"Chronic HBV Infection","enrollment":178},{"nctId":"NCT02814461","phase":"PHASE1","title":"The Safety and Maximum Tolerated Dose of Axitinib in Combination With Radiotherapy for HCC","status":"COMPLETED","sponsor":"Shin Kong Wu Ho-Su Memorial Hospital","startDate":"2015-11","conditions":"Advanced Hepatocellular Carcinoma (HCC)","enrollment":9},{"nctId":"NCT02058108","phase":"PHASE3","title":"Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus Infection","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2014-10-31","conditions":"Chronic Hepatitis B","enrollment":53},{"nctId":"NCT02787486","phase":"","title":"Expanded Noninvasive Genomic Medical Assessment: The Enigma Study","status":"COMPLETED","sponsor":"Progenity, Inc.","startDate":"2015-10","conditions":"Down Syndrome, Edwards Syndrome, Patau Syndrome","enrollment":760},{"nctId":"NCT03969017","phase":"PHASE2","title":"Combination Treatment of NAs and Peg IFN α-2b for Hepatitis B Related, Compensatory Cirrhosis Patients","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2019-06-17","conditions":"Cirrhosis of Liver Due to Hepatitis B (Disorder)","enrollment":84},{"nctId":"NCT03977987","phase":"","title":"Maternal Antiviral Treatment and Infants Immunoprophylaxis in the Prevention of Mother-to-child Transmission","status":"COMPLETED","sponsor":"Huashan Hospital","startDate":"2011-01-01","conditions":"Hepatitis B","enrollment":233},{"nctId":"NCT02774837","phase":"PHASE4","title":"Tenofovir Versus Tenofovir + Telbivudine for Chronic Hepatitis B","status":"UNKNOWN","sponsor":"Seng Gee Lim","startDate":"2016-04","conditions":"Chronic Hepatitis B","enrollment":146},{"nctId":"NCT03778567","phase":"PHASE4","title":"Renoprotective Effects of Telbivudine in Chronic Hepatitis B","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2013-08-01","conditions":"Hepatitis B, Chronic, Chronic Kidney Diseases","enrollment":31},{"nctId":"NCT01379508","phase":"PHASE4","title":"Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2011-03-21","conditions":"Chronic Hepatitis B","enrollment":241},{"nctId":"NCT02338674","phase":"PHASE1, PHASE2","title":"TDF and LdT in Immune-tolerant CHB Patients Awaiting Assisted Reproduction","status":"COMPLETED","sponsor":"Fuzhou General Hospital","startDate":"2014-10","conditions":"Hepatitis B, Chronic","enrollment":121},{"nctId":"NCT03468907","phase":"PHASE4","title":"The Safety of Anti-viral Therapy in Preventing HBV MTCT in Pregnant Women After Discontinuation","status":"COMPLETED","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2015-06-01","conditions":"Hepatitis B, Chronic","enrollment":111},{"nctId":"NCT02019966","phase":"","title":"A Korean Cohort Study of TDF Rescue Therapy for Difficult-to-treat CHB Patients: a Comparison Between TDF Monotherapy and TDF-based Combination Therapy","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2014-05-12","conditions":"The Difficult-to-treat Chronic Hepatitis B","enrollment":1020},{"nctId":"NCT01521975","phase":"PHASE4","title":"A Two-year Study of Telbivudine in HBeAg Negative Hepatitis","status":"COMPLETED","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2011-01-01","conditions":"Hepatitis B, Chronic","enrollment":360},{"nctId":"NCT01065818","phase":"NA","title":"Early Prediction of Pathology Response of Chemoradiotherapy With FLT PET","status":"TERMINATED","sponsor":"Columbia University","startDate":"2009-08","conditions":"Esophageal Cancer, Non-small Cell Lung Cancer","enrollment":6},{"nctId":"NCT00537537","phase":"PHASE4","title":"To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB)","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2007-08","conditions":"Hepatitis B, Chronic","enrollment":100},{"nctId":"NCT00467545","phase":"PHASE4","title":"An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2007-04","conditions":"Chronic Hepatitis B","enrollment":44},{"nctId":"NCT00646503","phase":"PHASE4","title":"Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B","status":"COMPLETED","sponsor":"Novartis","startDate":"2008-03","conditions":"Hepatitis B, Chronic","enrollment":150},{"nctId":"NCT00128544","phase":"PHASE2","title":"Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis B","status":"COMPLETED","sponsor":"Novartis","startDate":"2005-05","conditions":"Hepatitis B","enrollment":130},{"nctId":"NCT00640588","phase":"PHASE3","title":"Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With Telbivudine","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2008-03","conditions":"Hepatitis B, Chronic","enrollment":30},{"nctId":"NCT01207895","phase":"PHASE1","title":"Molecular Determinants Affecting Fluoro-L-thymidine (FLT) Positron Emission Tomography (PET) in Rectal Cancer","status":"COMPLETED","sponsor":"Vanderbilt-Ingram Cancer Center","startDate":"2010-03","conditions":"Rectal Cancer","enrollment":5},{"nctId":"NCT00781105","phase":"PHASE4","title":"Efficacy and Safety of Telbivudine 600mg Tablets in Chinese Patients With Chronic Hepatitis B","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2008-08-01","conditions":"Chronic Hepatitis B","enrollment":2200},{"nctId":"NCT00132652","phase":"PHASE3","title":"Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis B","status":"COMPLETED","sponsor":"Novartis","startDate":"2005-02","conditions":"Chronic Hepatitis B","enrollment":240},{"nctId":"NCT02447705","phase":"PHASE2, PHASE3","title":"Replacement of Lamivudine by Telbivudine to Improve Renal Function","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2013-06","conditions":"Disorder Related to Transplantation, Virus Diseases, Injury Due to Exposure to External Cause","enrollment":120},{"nctId":"NCT01595685","phase":"PHASE3","title":"Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis B","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2012-05","conditions":"Chronic Viral Hepatitis B Without Delta-agent","enrollment":98},{"nctId":"NCT00862706","phase":"PHASE4","title":"Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 Weeks","status":"WITHDRAWN","sponsor":"Novartis Pharmaceuticals","startDate":"2009-04","conditions":"Compensated Chronic Hepatitis B","enrollment":""},{"nctId":"NCT02894554","phase":"PHASE4","title":"Renal Function Improvement in HBsAg Positive Kidney Transplantation Patients Under Telbivudine Treatment.","status":"TERMINATED","sponsor":"National Taiwan University Hospital","startDate":"2014-07","conditions":"HBsAg-positive Renal Allograft Recipients","enrollment":19},{"nctId":"NCT02049736","phase":"NA","title":"Effect of Telbivudine on Renal Function and Proteinuria in Patients With CHB & Chronic Renal Diseases","status":"WITHDRAWN","sponsor":"Chinese University of Hong Kong","startDate":"2013-12","conditions":"Chronic Hepatitis B","enrollment":""},{"nctId":"NCT02826070","phase":"PHASE4","title":"EFFORT Further Extension Study","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2015-04","conditions":"Hepatitis B, Chronic","enrollment":130},{"nctId":"NCT01047059","phase":"PHASE2","title":"Molecular Imaging With Erlotinib and Bevacizumab","status":"COMPLETED","sponsor":"University of Cologne","startDate":"2010-01","conditions":"Non-Small-Cell Lung Carcinoma","enrollment":40},{"nctId":"NCT01732224","phase":"NA","title":"To Compare the Efficacy of Combined Tenofovir Plus Telbivudine vs Tenofovir Alone in Patients With Spontaneous Reactivation of Hepatitis B","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2012-11","conditions":"Spontaneous Reactivation of Hepatitis B","enrollment":69},{"nctId":"NCT00970216","phase":"","title":"Study of Telbivudine in Chronic Hepatitis B","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2009-02","conditions":"Chronic Hepatitis B","enrollment":160},{"nctId":"NCT02241668","phase":"NA","title":"Fluoro-L-Thymidine Positron Emission Tomography (FLT PET) vs. Adv. Magnetic Resonance (MR) Techniques in Recurrent Glioma","status":"WITHDRAWN","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-06","conditions":"Brain Tumor","enrollment":""},{"nctId":"NCT02615639","phase":"PHASE1, PHASE2","title":"A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHB","status":"UNKNOWN","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2015-11","conditions":"Chronic Hepatitis B","enrollment":450},{"nctId":"NCT01260610","phase":"NA","title":"Randomized Controlled Study of Tenofovir Plus Telbivudine Versus Monotherapy With Either Drug in HBeAg Negative Chronic Hepatitis B Patients","status":"WITHDRAWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2011-06","conditions":"Chronic Hepatitis B","enrollment":""},{"nctId":"NCT00124241","phase":"PHASE2","title":"An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B","status":"COMPLETED","sponsor":"Novartis","startDate":"","conditions":"Hepatitis B","enrollment":""},{"nctId":"NCT00131742","phase":"PHASE3","title":"Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B","status":"COMPLETED","sponsor":"Novartis","startDate":"2004-07","conditions":"Chronic Hepatitis B","enrollment":""},{"nctId":"NCT00115245","phase":"PHASE3","title":"Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B","status":"COMPLETED","sponsor":"Novartis","startDate":"2004-11","conditions":"Chronic Hepatitis B","enrollment":""},{"nctId":"NCT02005146","phase":"","title":"Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide Analogs","status":"COMPLETED","sponsor":"Fundación Pública Andaluza Progreso y Salud","startDate":"2013-12","conditions":"Chronic Hepatitis B Treated With Nucleoside/Nucleotide Analogues","enrollment":86},{"nctId":"NCT00057265","phase":"PHASE3","title":"A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis B","status":"COMPLETED","sponsor":"Novartis","startDate":"2003-02","conditions":"Chronic Hepatitis B","enrollment":""},{"nctId":"NCT00412529","phase":"PHASE3","title":"Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2006-12","conditions":"Hepatitis B, Chronic Hepatitis B","enrollment":44},{"nctId":"NCT01005238","phase":"PHASE4","title":"Telbivudine Versus Lamivudine for Maintenance Therapy of Patients With Chronic Hepatitis B and Negative HBV Viral Load After 6 Month of Treatment With Telbivudine","status":"TERMINATED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2009-09","conditions":"Hepatitis, Chronic","enrollment":27},{"nctId":"NCT00409019","phase":"PHASE4","title":"Trial of Telbivudine Combination Therapy vs. Continued Adefovir Monotherapy","status":"WITHDRAWN","sponsor":"Novartis Pharmaceuticals","startDate":"","conditions":"Chronic Hepatitis B","enrollment":""},{"nctId":"NCT01637844","phase":"PHASE4","title":"Telbivudine Therapy in HBeAg-positive Pregnant Women to Prevent Mother-to-infant Transmission of HBV","status":"COMPLETED","sponsor":"Yi-Hua Zhou","startDate":"2012-04","conditions":"HBV","enrollment":335},{"nctId":"NCT02301650","phase":"","title":"The Effect of Anti-viral Drugs Used in Late Pregnancy on Long-term Development of Children","status":"UNKNOWN","sponsor":"Beijing Ditan Hospital","startDate":"2014-10","conditions":"the Safety of Anti-viral Drugs Used in Late Pregnancy","enrollment":400},{"nctId":"NCT02253485","phase":"","title":"Efficacy of Antiviral Therapy in Pregnancy in Preventing Vertical Transmission of HBV in Mothers With a High Viral Load","status":"UNKNOWN","sponsor":"Beijing Ditan Hospital","startDate":"2012-08","conditions":"Immune Globulin, Prophylaxis, Telbuvidine, Vaccine","enrollment":600},{"nctId":"NCT01529255","phase":"PHASE4","title":"EFFORT Extension Study","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2011-08","conditions":"Hepatitis B, Chronic","enrollment":576},{"nctId":"NCT00651209","phase":"PHASE4","title":"A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB)","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2008-02","conditions":"Hepatitis B, Chronic","enrollment":105},{"nctId":"NCT02069418","phase":"PHASE2","title":"Theranostic Tool During Erlotinib Treatment in Non-small Cell Lung Cancer Patient","status":"UNKNOWN","sponsor":"University Hospital, Angers","startDate":"2014-02","conditions":"Non-small Cell Lung Cancer Metastatic or Non-small Cell Lung Cancer Recurrent, No EGFR Activating Mutation","enrollment":80},{"nctId":"NCT01597934","phase":"PHASE4","title":"Antiviral Efficacy of Switching to ETV Plus TDF","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2012-08","conditions":"Chronic Hepatitis B","enrollment":104},{"nctId":"NCT01958229","phase":"","title":"Efficacy Study of Telbivudine in Chronic Hepatitis B Patients","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2009-12","conditions":"Chronic Hepatitis B, Roadmap Concept in Chronic Hepatitis B Treatment, 24-week PCR Negativity of Telbivudine","enrollment":23},{"nctId":"NCT01743079","phase":"PHASE4","title":"Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis B","status":"COMPLETED","sponsor":"Beijing YouAn Hospital","startDate":"2009-01","conditions":"Chronic Hepatitis B, Late Pregnancy, Transmission","enrollment":700},{"nctId":"NCT01788371","phase":"PHASE4","title":"Nucleoside Analogue Prevent Vertical Transmission of Hepatitis B Virus","status":"COMPLETED","sponsor":"Hua Zhang","startDate":"2009-03","conditions":"Hepatitis B Infection, Chronic Infection, Viremia","enrollment":700},{"nctId":"NCT01804387","phase":"PHASE4","title":"Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot Study","status":"UNKNOWN","sponsor":"Korea University","startDate":"2011-05","conditions":"Chronic Hepatitis B","enrollment":60},{"nctId":"NCT01799486","phase":"PHASE4","title":"Telbivudine Renoprotective Effect in Patients With the HBV-related Liver Cirrhosis: a Randomized Controlled Trial","status":"UNKNOWN","sponsor":"Lin Bingliang","startDate":"2013-02","conditions":"HBV-related Liver Cirrhosis","enrollment":300},{"nctId":"NCT00962533","phase":"PHASE4","title":"EFFicacy Optimization Research of Telbivudine Therapy","status":"COMPLETED","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2009-08","conditions":"Hepatitis B, Chronic","enrollment":606},{"nctId":"NCT01693679","phase":"PHASE4","title":"Telbivudine Renoprotective Effect in Patients With HBV-related Liver Cirrhosis","status":"UNKNOWN","sponsor":"Shao-quan Zhang","startDate":"2012-09","conditions":"HBV-related Liver Cirrhosis","enrollment":120},{"nctId":"NCT01204827","phase":"PHASE2, PHASE3","title":"Follow Up of Patients Chronic Hepatitis B (CHB) Treated With Sebivo Using the 13C Methacetin Breath Test","status":"WITHDRAWN","sponsor":"Hadassah Medical Organization","startDate":"","conditions":"Chronic Hepatitis B","enrollment":""},{"nctId":"NCT00804622","phase":"PHASE2","title":"Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2008-12","conditions":"Chronic Hepatitis B","enrollment":15},{"nctId":"NCT00778596","phase":"PHASE4","title":"Prednisolone Priming Study in Patients With Chronic Hepatitis B","status":"UNKNOWN","sponsor":"Yun-Fan Liaw","startDate":"2009-02","conditions":"Chronic Hepatitis B","enrollment":160},{"nctId":"NCT01595633","phase":"PHASE4","title":"Switch From Adefovir to Tenofovir in Chronic Hepatitis B for Suboptimal Response to Adefovir-based Combination Therapy","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2012-03","conditions":"Chronic Hepatitis B","enrollment":124},{"nctId":"NCT00877149","phase":"PHASE4","title":"Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis B","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2009-03","conditions":"Compensated Chronic Hepatitis B","enrollment":80},{"nctId":"NCT01588912","phase":"PHASE4","title":"Efficacy of Telbivudine With or Without add-on Tenofovir According to Roadmap Strategy Compare With Entecavir","status":"UNKNOWN","sponsor":"Pusan National University Yangsan Hospital","startDate":"2012-04","conditions":"Chronic Hepatitis B","enrollment":104},{"nctId":"NCT00606099","phase":"PHASE4","title":"Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis B","status":"WITHDRAWN","sponsor":"Novartis","startDate":"2007-11","conditions":"Chronic Hepatitis B","enrollment":""},{"nctId":"NCT00805675","phase":"PHASE3","title":"Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHB","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2008-11","conditions":"Hepatitis B Virus","enrollment":83},{"nctId":"NCT01270165","phase":"PHASE3","title":"Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis B","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2010-06","conditions":"Chronic Hepatitis B","enrollment":110},{"nctId":"NCT01480492","phase":"NA","title":"Effect of Antiviral Therapy on Host Immune in Patients With Chronic Hepatitis B Virus(HBV) Infection","status":"COMPLETED","sponsor":"Cz Li","startDate":"2010-01","conditions":"HBeAg Positive Chronic Hepatitis B Infection","enrollment":56},{"nctId":"NCT00145665","phase":"PHASE1, PHASE2","title":"The Role of Fluorothymidine Positron Emission Tomography (FLT-PET) in Proliferation of Colorectal Liver Metastases","status":"TERMINATED","sponsor":"Radboud University Medical Center","startDate":"2005-01","conditions":"Colorectal Neoplasms, Liver Neoplasms","enrollment":80},{"nctId":"NCT00076336","phase":"PHASE3","title":"Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2003-12","conditions":"Hepatitis, Hepatitis B, Chronic, Cirrhosis","enrollment":232},{"nctId":"NCT00412750","phase":"PHASE3","title":"Efficacy and Safety of Telbivudine in Treatment naïve Patients With Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB)","status":"TERMINATED","sponsor":"Novartis","startDate":"2006-12","conditions":"Hepatitis B","enrollment":159},{"nctId":"NCT00376259","phase":"PHASE3","title":"Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone","status":"TERMINATED","sponsor":"Novartis","startDate":"2007-01","conditions":"Hepatitis B","enrollment":43},{"nctId":"NCT01380951","phase":"PHASE4","title":"Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB)","status":"UNKNOWN","sponsor":"The Fifth People's Hospital of Suzhou","startDate":"2011-05","conditions":"Liver Cirrhosis, Chronic Hepatitis B","enrollment":120},{"nctId":"NCT01337791","phase":"PHASE4","title":"Efficacy, Safety and Tolerability of Telbivudine in HBeAg Positive Chronic Hepatitis B Pregnant Women With Elevated Alanine Aminotransferase Levels","status":"COMPLETED","sponsor":"Southeast University, China","startDate":"2008-08","conditions":"Chronic Hepatitis B, Pregnancy Complications, High Viral Load","enrollment":88},{"nctId":"NCT00275652","phase":"PHASE3","title":"A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis.","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2004-06","conditions":"Hepatitis B, Cirrhosis","enrollment":6},{"nctId":"NCT01083251","phase":"NA","title":"The Beneficial Effect of Vitamin D Supplement to Peg Interferon Alpha 2a or to Telbivudine Monotherapy in Patients With Chronic Hepatitis B Virus (HBV) Infection","status":"UNKNOWN","sponsor":"Ziv Hospital","startDate":"2010-03","conditions":"Hepatitis B Virus","enrollment":120},{"nctId":"NCT01155427","phase":"","title":"Systematic Review of Antiretroviral Treatments for Chronic Hepatitis B (CHB)","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2009-05","conditions":"Hepatitis B, Chronic","enrollment":100},{"nctId":"NCT01102335","phase":"PHASE4","title":"Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy","status":"UNKNOWN","sponsor":"Fudan University","startDate":"2010-04","conditions":"Hepatocellular Carcinoma","enrollment":80},{"nctId":"NCT01089894","phase":"","title":"Clinical Application of 18F-3'-Fluoro-3'-Deoxy-L-thymidine (18F-FLT) Positron Emission Tomography (PET) in Lung Tumors","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2008-08","conditions":"Lung Cancer","enrollment":90},{"nctId":"NCT00939068","phase":"PHASE4","title":"Efficacy and Safety Study of Telbivudine to Prevent Perinatal Transmission","status":"UNKNOWN","sponsor":"Southeast University, China","startDate":"2008-02","conditions":"Chronic Hepatitis B, Gestation","enrollment":180},{"nctId":"NCT00710216","phase":"PHASE4","title":"Comparison of Telbivudine Versus Lamivudine on the Early Dynamics and Kinetics of Viral Suppression in Chronic Hepatitis B","status":"WITHDRAWN","sponsor":"University of Ulm","startDate":"","conditions":"Hepatitis B, Chronic","enrollment":40},{"nctId":"NCT00810524","phase":"PHASE4","title":"Influence of Antiviral Treatment to the Long-Term Prognosis of Patients With Chronic HBV Infection","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2007-01","conditions":"Hepatitis B, Chronic","enrollment":600}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Infectious Disease"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"phase_1","status":"active","brandName":"Sebivo","genericName":"Sebivo","companyName":"Ziv Hospital","companyId":"ziv-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sebivo is a small molecule drug that belongs to the class of inhibitors, specifically targeting DNA polymerase/reverse transcriptase. It is used to treat hepatitis B infection and has been shown to be more effective than lamivudine or adefovir in clinical trials.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}